Background: The human gut microbiota is assembled during infancy with an increase in diversity and stability. The correct colonization and the establishment of this microbiome are linked to the early and future health status of the individual. It is known that caesarean delivery alters this optimal microbial foundation. C-section (CS) is a common obstetrician surgery; however, it is not without risk for the mother/infant dyad. The World Health Organization recommends not exceeding 10–15% of the total deliveries; nevertheless, this rate has been increasing rapidly worldwide in the last decades. Summary: This review discloses the clinical parameters for correct CS recommendation. Moreover, the major microbial changes in the infant gut microbiome acquisition as a consequence of delivery mode and medical practices surrounding it, as well as, the early and long-lasting effects for both mother and babies are discussed. In addition, some strategies for the gut microbiota restoration are analysed. The aim of this review is to show the need for the development of strategies for minimizing or limiting the impact of caesarean on the microbiome development, favouring future health.

Keywords:
Infant, Gut, Microbiota, C-section, Health, Restoration strategies, Delivery mode
1.
WHO/RHR/15.02: World Health Organization 2015. Statement on Caesarean section rates, 2015.
2.
Signore C, Klebanoff M: Neonatal morbidity and mortality after elective cesarean delivery. Clin Perinatol 2008; 35: 361–371, vi.
3.
Mylonas I, Friese K: Indications for and risks of elective Cesarean section. Dtsch Arztebl Int 2015; 112: 489–495.
4.
Grabovac M, Karim JN, Isayama T, Liyanage SK, McDonald SD: What is the safest mode of birth for extremely preterm breech singleton infants who are actively resuscitated? A systematic review and meta-analyses. BJOG 2017; 125: 652–663.
5.
Kennedy CE, Yeh PT, Pandey S, Betran AP, Narasimhan M: Elective cesarean section for women living with HIV: a systematic review of risks and benefits. AIDS (London, England) 2017; 31: 1579–1591.
6.
Lagrew DC, Low LK, Brennan R, Corry MP, Edmonds JK, Gilpin BG, Frost J, Pinger W, Reisner DP, Jaffer S: National partnership for maternal safety: Consensus bundle on safe reduction of primary Cesarean births-supporting intended vaginal births. J Obstet Gynecol 2018; 131: 503–513.
7.
Betran AP, Ye J, Moller AB, Zhang J, Gulmezoglu AM, Torloni MR: The increasing trend in Caesarean section rates: Global, regional and national estimates: 1990–2014. PLoS One 2016; 11:e0148343.
8.
Smaill FM, Grivell RM: Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2014; 10:CD007482.
9.
Meropol SB, Edwards A: Development of the infant intestinal microbiome: a bird's eye view of a complex process. Birth Defects Res C Embryo Today 2015; 105: 228–239.
10.
Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, Belzer C, Delgado Palacio S, Arboleya Montes S, Mancabelli L, Lugli GA, Rodriguez JM, Bode L, de Vos W, Gueimonde M, Margolles A, van Sinderen D, Ventura M: The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev 2017; 81:pii:e00036-17.
11.
Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R: Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010; 107: 11971–11975.
12.
Shi YC, Guo H, Chen J, Sun G, Ren RR, Guo MZ, Peng LH, Yang YS: Initial meconium microbiome in Chinese neonates delivered naturally or by cesarean section. Sci Rep 2018; 8: 3255.
13.
Rutayisire E, Huang K, Liu Y, Tao F: The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review. BMC Gastroenterol 2016; 16: 86.
14.
Salminen S, Gibson GR, McCartney AL, Isolauri E: Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 2004; 53: 1388.
15.
Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, Li Y, Xia Y, Xie H, Zhong H, Khan MT, Zhang J, Li J, Xiao L, Al-Aama J, Zhang D, Lee YS, Kotowska D, Colding C, Tremaroli V, Yin Y, Bergman S, Xu X, Madsen L, Kristiansen K, Dahlgren J, Wang J: Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015; 17: 852.
16.
Jakobsson HE, Abrahamsson TR, Jenmalm MC, Harris K, Quince C, Jernberg C, Bjorksten B, Engstrand L, Andersson AF: Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut 2014; 63: 559–566.
17.
Gregory KE, LaPlante RD, Shan G, Kumar DV, Gregas M: Mode of birth influences preterm infant intestinal colonization with Bacteroides over the early neonatal period. Adv Neonatal Care 2015; 15: 386–393.
18.
Gundersen TD, Krebs L, Loekkegaard ECL, Rasmussen SC, Glavind J, Clausen TD: Postpartum urinary tract infection by mode of delivery: a Danish nationwide cohort study. BMJ Open 2018; 8:e018479.
19.
Malamitsi-Puchner A, Protonotariou E, Boutsikou T, Makrakis E, Sarandakou A, Creatsas G: The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum Dev 2005; 81: 387–392.
20.
Costa-Ramón AM, Rodríguez-González A, Serra-Burriel M, Campillo-Artero C: It’s about time: cesarean sections and neonatal health. J Health Econ 2018; 59: 46–59.
21.
Bager P, Wohlfahrt J, Westergaard T: Caesarean delivery and risk of atopy and allergic disease: meta-analyses. Clin Exp Allergy 2008; 38: 634–642.
22.
Thavagnanam S, Fleming J, Bromley A, Shields MD, Cardwell CR: A meta-analysis of the association between Caesarean section and childhood asthma. Clin Exp Allergy 2008; 38: 629–633.
23.
Decker E, Engelmann G, Findeisen A, Gerner P, Laass M, Ney D, Posovszky C, Hoy L, Hornef MW: Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Pediatrics 2010; 125:e1433–e1440.
24.
Pei Z, Heinrich J, Fuertes E, Flexeder C, Hoffmann B, Lehmann I, Schaaf B, von Berg A, Koletzko S: Cesarean delivery and risk of childhood obesity. J Pediatr 2014; 164: 1068–1073.e1062.
25.
Mueller NT, Mao G, Bennet WL, Hourigan SK, Dominguez-Bello MG, Appel LJ, Wang X: Does vaginal delivery mitigate or strengthen the intergenerational association of overweight and obesity? Findings from the Boston Birth Cohort. Int J Obes 2017; 41: 497–501.
26.
Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, Parslow RC, Pozzilli P, Brigis G, Stoyanov D, Urbonaite B, Sipetic S, Schober E, Ionescu-Tirgoviste C, Devoti G, de Beaufort CE, Buschard K, Patterson CC: Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 2008; 51: 726–735.
27.
Horta BL, Gigante DP, Lima RC, Barros FC, Victora CG: Birth by caesarean section and prevalence of risk factors for non-communicable diseases in young adults: a birth cohort study. PLoS One 2013; 8:e74301.
28.
Dominguez-Bello MG, De Jesus-Laboy KM, Shen N, Cox LM, Amir A, Gonzalez A, Bokulich NA, Song SJ, Hoashi M, Rivera-Vinas JI, Mendez K, Knight R, Clemente JC: Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 2016; 22: 250–253.
29.
Cunnington AJ, Sim K, Deierl A, Kroll JS, Brannigan E, Darby J: “Vaginal seeding” of infants born by caesarean section. BMJ 2016; 352:i227.
30.
Laursen MF, Bahl MI, Michaelsen KF, Licht TR: First foods and gut microbes. Front Microbiol 2017; 8: 356.
31.
Le Doare K, Holder B, Bassett A, Pannaraj PS: Mother's milk: A purposeful contribution to the development of the infant microbiota and immunity. Front Immunol 2018; 9: 361.
32.
Garcia Rodenas CL, Lepage M, Ngom-Bru C, Fotiou A, Papagaroufalis K, Berger B: Effect of formula containing Lactobacillus reuteri DSM 17938 on fecal microbiota of infants born by Cesarean-section. J Pediatr Gastroenterol Nutr 2016; 63: 681–687.
33.
Baglatzi L, Gavrili S, Stamouli K, Zachaki S, Favre L, Pecquet S, Benyacoub J, Costalos C: Effect of infant formula containing a low dose of the probiotic Bifidobacterium lactis CNCM I-3446 on immune and gut functions in C-Section delivered babies: a pilot study. Clin Med Insights Pediatr 2016; 10: 11–19.
34.
Chua MC, Ben-Amor K, Lay C, Neo AGE, Chiang WC, Rao R, Chew C, Chaithongwongwatthana S, Khemapech N, Knol J, Chongsrisawat V: Effect of synbiotic on the gut microbiota of Cesarean delivered infants: a randomized, double-blind, multicenter study. J Pediatr Gastroenterol Nutr 2017; 65: 102–106.
35.
Nogacka A, Salazar N, Suarez M, Milani C, Arboleya S, Solis G, Fernandez N, Alaez L, Hernandez-Barranco AM, de Los Reyes-Gavilan CG, Ventura M, Gueimonde M: Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates. Microbiome 2017; 5: 93.
36.
Moya-Perez A, Luczynski P, Renes IB, Wang S, Borre Y, Anthony Ryan C, Knol J, Stanton C, Dinan TG, Cryan JF: Intervention strategies for cesarean section-induced alterations in the microbiota-gut-brain axis. Nutr Rev 2017; 75: 225–240.
37.
Rutayisire E, Wu X, Huang K, Tao S, Chen Y, Tao F: Childhood emotional and behavior problems and their associations with cesarean delivery. Rev Bras Psiquiatr 2017; 20: 145–153.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.